Larry Case to Treatment Outcome
This is a "connection" page, showing publications Larry Case has written about Treatment Outcome.
Connection Strength
0.141
-
Miller AA, Al Omari A, Murry DJ, Case D. Phase I and pharmacologic study of sequential topotecan-carboplatin-etoposide in patients with extensive stage small cell lung cancer. Lung Cancer. 2006 Dec; 54(3):379-85.
Score: 0.036
-
Page BR, Shaw EG, Lu L, Bryant D, Grisell D, Lesser GJ, Monitto DC, Naughton MJ, Rapp SR, Savona SR, Shah S, Case D, Chan MD. Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue. Neuro Oncol. 2015 Oct; 17(10):1393-401.
Score: 0.016
-
Rapp SR, Case LD, Peiffer A, Naughton MM, Chan MD, Stieber VW, Moore DF, Falchuk SC, Piephoff JV, Edenfield WJ, Giguere JK, Loghin ME, Shaw EG. Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical Trial. J Clin Oncol. 2015 May 20; 33(15):1653-9.
Score: 0.016
-
Lee TC, Ivester P, Hester AG, Sergeant S, Case LD, Morgan T, Kouba EO, Chilton FH. The impact of polyunsaturated fatty acid-based dietary supplements on disease biomarkers in a metabolic syndrome/diabetes population. Lipids Health Dis. 2014 Dec 16; 13:196.
Score: 0.016
-
Lawrence JA, Akman SA, Melin SA, Case LD, Schwartz GG. Oral paricalcitol (19-nor-1,25-dihydroxyvitamin D2) in women receiving chemotherapy for metastatic breast cancer: a feasibility trial. . 2013 Jun; 14(6):476-80.
Score: 0.014
-
Ivester P, Sergeant S, Danhauer SC, Case LD, Lamb A, Chilton BG, Delar B, Hollingshead ML, Weaver KL, Chilton FH. Effect of a multifaceted, church-based wellness program on metabolic syndrome in 41 overweight or obese congregants. Prev Chronic Dis. 2010 Jul; 7(4):A81.
Score: 0.012
-
Gallahan WC, Case D, Bloomfeld RS. An analysis of the placebo effect in Crohn's disease over time. Aliment Pharmacol Ther. 2010 Jan; 31(1):102-7.
Score: 0.011
-
Stroud N, Mazwi TM, Case LD, Brown RD, Brott TG, Worrall BB, Meschia JF. Prestroke physical activity and early functional status after stroke. J Neurol Neurosurg Psychiatry. 2009 Sep; 80(9):1019-22.
Score: 0.011
-
Miller AA, Case D, Harmon M, Savage P, Lesser G, Hurd D, Melin SA. Phase I study of lenalidomide in solid tumors. J Thorac Oncol. 2007 May; 2(5):445-9.
Score: 0.009